Brian Elsbernd - Mar 20, 2023 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Compliance/Legal Officer
Signature
/s/ Brian Elsbernd
Stock symbol
CPRX
Transactions as of
Mar 20, 2023
Transactions value $
-$746,950
Form type
4
Date filed
3/22/2023, 04:45 PM
Previous filing
Feb 17, 2023
Next filing
Dec 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common Stock, par value $0.001 per share Options Exercise $56.5K +50K +36.21% $1.13* 188K Mar 20, 2023 Direct
transaction CPRX Common Stock, par value $0.001 per share Sale -$803K -50K -26.58% $16.07 138K Mar 20, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to Purchase Common Stock Options Exercise $0 -50K -5.49% $0.00 860K Mar 20, 2023 Common Stock 50K $1.13 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Mr. Elsbernd sold the shares in the open market for personal reasons and not as a result of a disagreement with the Company. Mr. Elsbernd remains an executive officer of the Company.
F2 Represents the weighted average price for the shares sold. Shares were sold in various lots ranging from $16.01 to $16.23 per share.
F3 Options vested in three annual tranches beginning on 1/3/2018.